| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc. (ABBV) has 5 insiders with recent SEC Form 4 filings, including 11 buys and 2 sells. ABBV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 177.3K | $38.38M | - | |
| VP | 68.3K | $14.79M | - | |
| Dir | 28.5K | $6.17M | - | |
| Dir | 10.3K | $2.22M | - | |
| Dir | 707 | $153.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2020 | Richmond Timothy J.47 | EVP, Chief Hr Officer | Sell | 19,445 | $85.00 | $1,652,825.00 | -100% | |
| Mar 30, 2020 | Durkin Brian L | VP, Controller | Buy | 3,750 | $68.20 | $255,754.80 | +8.4% | |
| Mar 3, 2020 | Rapp Edward J | Director | Buy | 2,875 | $87.87 | $252,617.05 | New | |
| Sep 27, 2019 | Richmond Timothy J.47 | EVP, Chief Hr Officer | Sell | 15,515 | $75.02 | $1,163,873.24 | -100% | |
| Sep 16, 2019 | Schumacher Laura J | Vice Chairman | Buy | 25,000 | $70.42 | $1,760,522.50 | +17.9% | |
| Aug 29, 2019 | Donoghoe Nicholas | SVP, Enterprise Innovation | Buy | 7,525 | $66.19 | $498,057.18 | +135.2% | |
| Aug 16, 2019 | Stewart Jeffrey Ryan | SVP, Us Commercial Operations | Buy | 15,552 | $64.44 | $1,002,169.32 | +31.3% | |
| Aug 1, 2019 | Austin Roxanne S59 | Director | Buy | 55,000 | $65.86 | $3,622,090.00 | +35.7% | |
| Jul 30, 2019 | Austin Roxanne S59 | Director | Buy | 10,000 | $66.35 | $663,500.00 | +19.2% | |
| Jul 29, 2019 | Gosebruch Henry O53 | EVP, Chief Strategy Officer | Buy | 30,000 | $67.28 | $2,018,385.00 | +65.6% |